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A general mechanism
for nonenzymatic
glucosylation
of
protein is outlined
in Fig. 1. Free amino groups in protein
react with the acyclic form of glucose to yield a Schiff-base
intermediate
which can undergo the Amadori Rearrangement
to a stable ketoamine
derivative,
which then cyclizes to the
hemiketal structure (2). Prolonged elevation of blood glucose
in diabetes causes an increase in levels of nonenzymatically
glucosylated hemoglobin,
HbAr,, in erythrocytes
(3); this posttranslational
modification
affects hemoglobin’s
oxygen affinity
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(4, 5) and sensitivity to the allosteric effector, 2,3-diphosphoglycerate (5, 6). It has been hypothesized
(7) that nonenzymatic glucosylation
of other body proteins may also induce
changes in their chemical, physical, and ultimately,
biological
properties, leading eventually
to the pathological
sequelae of
diabetes. This hypothesis is supported by a growing body of
evidence from clinical experience
(8, 9) and animal model
studies (lo), which indicates that chronic, subclinical
hyperglycemia, rather than the insulin deficiency itself, may be the
major factor contributing
to the progressive, secondary complications of diabetes. Stevens et al. (11) have, in fact, recently
demonstrated
that nonenzymatic
glucosylation
of cy-crystallins
in lens cultures in vitro causes aggregation
and precipitation
of the crystallins.
Their observations
suggest that a similar
process occurring in uiuo may contribute
to the development
of cataracts in diabetic patients.
In a recent communication
(12) we reported that several
classes of human serum proteins are also subject to nonenzymatic glucosylation
in vitro, and that albumin isolated from
normal human serum contains about 8% of a glucosylated
derivative. Bailey et al. have also detected glucosylated lysine
residues in albumin, erythrocyte membrane proteins (13), and
collagens (14). Thus, it appears that numerous proteins in the
body may be continuously
modified by nonenzymatic
glucosylation. By analogy to the observations with hemoglobin,
the
rates and extents of glucosylation
of other proteins may also
be enhanced in diabetic hyperglycemia.
Identification
of specific proteins subject to nonenzymatic
glucosylation
and its effects on protein function and metabolism are essential for evaluating the hypothesized
relationship
between hyperglycemia
and the chronic pathophysiology
of
diabetes. Since much of this work can be most readily carried
out in animal model systems, we have undertaken
a study of
serum protein glucosylation
in the rat, in order to establish
that this animal will be a satisfactory model for the human
system. We present here in vitro experiments parallel to those
previously reported for glucosylation
of human serum proteins
(12) as well as studies on the physical and chemical parameters
affecting the kinetics of glucosylation.
In addition,
in uivo
studies are reported
identifying
the body compartment
in
which glucosylation
occurs, and the effect of glucosylation
on
the survival of albumin in the circulation. Finally, we establish,
for the first time, that the serum concentration
of glucosylated
albumin is significantly
elevated in diabetic rata.
MATERIALS

AND

METHODS

Rat serum albumin
was prepared
from fresh rat serum by affinity
chromatography
on Affi-Gel
Blue (Bio-Rad)
(151, followed
by gel
chromatography
on Bio-Gel
P-156 (Bio-Rad),
or purchased
from
Miles Laboratories.
n-[B-“H]Glucose
(34 Ci/mmol),
L-[3,4,5-3H]leuserine
(1 to 5 Ci/mmol)
were
tine (129.8 Ci/mmol)
and L-[G-“H]
purchased
from New England
Nuclear,
and Na”“I
(carrier-free)
from
Amersham/Searle.
Penicillin-streptomycin
was obtained
from Grand
Island Biological
Co.
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Incubation
of rat serum with o-[6-3H]glucose
in vitro
resulted
in nonenzymatic
glucosylation
of serum proteins. Analysis
of freshly
isolated
rat albumin
by ion
exchange
chromatography
indicated
that the glucosylated albumin
accounts
for 6.7 + 0.9% of total albumin
in normal
rat serum. Glucosylation
of rat albumin
in
vitro was first order with respect to glucose and albumin concentrations
and occurs primarily
(>90%) at intrachain
lysine residues.
Kinetic analysis
and inhibition
of glucosylation
by aspirin
suggest that 1 reactive
lysine residue
is the primary
site of glucosylation.
Less
than 5% of the radioactivity
from [6-3H]glucosyl-albumin was released
as glucose or mannose
by hydrolysis
conditions
normally
used for the analysis
of neutral
sugars in glycoproteins.
Studies
in viva demonstrated
that the half-life
of albumin
in normal
rats was unaffected by the addition
of 1 mol of glucose/mol
of albumin. In addition,
glucosylation
was found to be a stable
modification
since ‘251-albumin
isolated
up to 3 days
after
injection
of glucosylated
1261-albumin
was recovered
only in the glucosylated
fraction.
In contrast,
following
injection
of unglucosylated
‘2SI-albumin
there
was a gradual
shift of lz51 radioactivity
to the glucosylated albumin
fraction,
as would
be predicted
for nonenzymatic
glucosylation
occurring
in the circulation.
Finally,
levels of glucosylated
albumin
isolated
from
diabetic
rats (alloxan
induced)
were significantly
(4fold) elevated
4 days after withdrawal
from insulin
therapy.
These studies indicate
that the rat should be
a suitable
animal
model for in uivo studies on nonenzymatic glucosylation
of albumin
and other serum proteins in normal
and diabetic
metabolic
states.

Nonenzymatic

GLUCOSE

c/

Glucosylation

SCHIFF BASE

/

AMADORI

/
H2-NH-PROTEIN

bH

KETOAMINE
STRUCTURE
1. General
reaction
of protein.

scheme

for

the

PROTEIN

nonenzymatic

glu-

Incubations
Albumin
solutions
and rat serum containing
100 units/ml
of penicillin and 100 pg/ml
of streptomycin
were incubated
in the dark at
desired
temperatures.
Albumin
solutions
(5 to 50 mg/ml)
were prepared in Dulbecco’s
phosphate-buffered
saline (16) containing
1 to 50
mM glucose.
Serum was incubated
under an atmosphere
of 95% 02,
5% CO? to maintain
pH 7.3 to 7.4. Trace amounts
of [6-“HIglucose
were added to incubation
mixtures
to obtain desired specific activities.
Assays

Acid

Analyses

Proteins
in 6 N HCl were gassed with NZ in a sealed tube and
hydrolyzed
at 100°C for 24 h, and amino acid analyses
were carried
out on a Beckman
model 119-C analyzer.
For identification
of glucosylated
amino acids, n-[6-“HIglucose-labeled
albumin
was dissolved
in 0.1 M NaBH4
in 0.1 M NaOH,
to a final protein
concentration
of 7
mg/ml;
the mixture
was incubated
with shaking
at 25°C for 4 h and
then dialyzed
and lyophilized.
Following
hydrolysis
of the reduced,
glucosylated
albumin
in 6 N HCl as described
above, the sample was
divided
in half. One portion
was analyzed
directly
for ninhydrinpositive
material.
L-[:‘H]Leucine
(70,000 cpm) and L-[:‘H]serine
(20,000
cpm) were added as internal
reference
standards
to the second portion, which was then applied to the analyzer
column,
but the effluent
from the column
was fed directly
into a fraction
collector;
fractions
were then counted
for radioactivity.
Glucitol-lysine
was prepared
from n-[6-‘H]glucose
and lysine as described
by Bailey et al. (13), and
purified
by chromatography
on Amberlite
MB (Mallinckrodt).
Carbohydrate

Half-life

Studies-Unglucosylated

RESULTS

gradually accumulates in
an acid-precipitable
fraction during the incubation
of rat
serum with tracer amounts of [6-“HIglucose
(Fig. 2). The
reaction rate was linear for at least 200 h at room temperature
by which time about 10% of glucose radioactivity
was incorporated into protein. Based on the approximate
specific activity of the [3H]glucose, 4 x 10” cpm/pmol, an average molecular
weight of serum proteins of 1 x 105, and a serum protein
concentration
of approximately
70 mg/ml, the incorporation
of 2 X 10” cpm into protein in 1 ml of serum represents an
average of 0.7 mol of glucose/m01 of protein.
Following
200 h of incubation,
reaction mixtures were dialyzed against pH 7.8, Tris-HCl at 4”C, overnight, with essentially quantitative
recovery of acid-precipitable
radioactivity.
When the dialysate was chromatographed
on Sephadex G-200

Analyses

Carbohydrates
were separated
by high pressure
liquid chromatography using the procedure
of Lee et al. (18.19).
For measurements
of
radioactivity
in glucose or mannose
following
acid hydrolysis
of D-[S‘HIglucose-labeled
albumin,
unlabeled
glucose
and mannose
were
added to samples
at the end of the hydrolysis;
the effluent
from the
column
was fed into a fraction
collector,
and aliquots
of the fractions
were monitored
for both carbohydrate,
using the anthrone
reagent
(20), and radioactivity.
In Vivo

the lactoperoxidase
method
(21) and labeled, monomeric
albumin
was
isolated
by Bio-Gel
P-150 chromatography;
the final specific
activity
was 1.3 x 10” cpm/mg.
Two milligrams
of this material
were glucosylated
in 20 mM glucose at 37°C for 3 days, and then separated
into
““I-glucosylated
and ““I-unglucosylated
albumin
by carboxymethylcellulose
chromatography.
Rats were injected
intracardially
with
either
1 mg of ‘2”I-glucosylated
or 0.85 mg of ““I-unglucosylated
albumin;
radioactivity
was determined
in 50 ~1 of plasma
samples
obtained
from lateral
tail veins (22) over a 4-day period in order to
compare
the circulating
half-lives
of the two forms of albumin.
In
separate
experiments,
1 ml of blood was removed
by cardiac
puncture
at 1 and 3 days postinjection
of each of the iodinated
forms
of
albumin.
Albumin
was reisolated
by affinity
chromatography
and
then carboxymethylcellulose
chromatography,
for determination
of
recovery
of Is51 radioactivity
in glucosylated
and unglucosylated
albumins.
Studies
with Diabetic
Rats-Rats
(male, Sprague-Dawley,
125 to
150 g) were made diabetic
by the intravenous
injection
of 35 mg/kg
of alloxan.
Animals
whose blood glucose
exceeded
300 mg/lOO
ml at
2 days postinjection
were classified
as diabetic.
These animals
were
then maintained
with daily subcutaneous
injections
of 4 units of
protamine
zinc insulin
for 2 weeks, when the therapy
was stopped.
Ninety-six
hours after the last insulin
injection,
the rats were anesthetized
with ether and 1 to 2 ml of blood were removed
by cardiac
puncture.
At the same time, blood was also obtained
from a second
set of alloxan-treated
rats maintained
on insulin therapy
throughout,
and from a sex-, age-, and weight-matched
control
group.
Blood
glucose
was determined
by a glucose
oxidase-peroxidase
method
(Sigma),
and serum albumin
was purified
and fractionated
into unglucosylated
and glucosylated
albumin
as described
above.

In Vitro Studies-Radioactivity

Acid-precipitable
radioactivity
was determined
by adding
25+1
aliquots
of incubation
mixtures
to 50 ~1 of a bovine serum albumin
solution
(10 mg/ml)
and precipitating
with 1 ml of cold 10% trichloroacetic
acid. Pellets were washed
twice by centrifugation
and the
final pellet was redissolved
in 500 ~1 of Hz0 and counted
for radioactivity in Beckman
Instruments
Co. Bio-Solv
EP.
Glucosylated
protein
was separated
from nonglucosylated
protein
by carboxymethylcellulose
chromatography
at pH 4.65 as previously
described
(12). Glucosylated
protein
was detected
using the thiobarbituric
acid procedure
of Fliickiger
and Winterhalter
(17) which
measures
5-hydroxymethylfurfural
released
following
hydrolysis
of
ketoamine
adducts
of protein.
Hydroxymethylfurfural
was used as
the standard
in these assays.
Amino
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Experiments
albumin

was

iodinated

using

FIG. 2. Time-dependent
formation
of acid-precipitable
[63H]glucose
radioactivity
in rat serum
in vitro.
One milliliter
of
rat serum was incubated
with 2 x 10’ cpm (-1 pg) of [6-“HIglucose
at
25°C under sterile conditions,
and aliquots
were removed
for determination
of acid-precipitable
radioactivity
as described
under “Materials and Methods.”
Data are expressed
as precipitable
counts per
min in total incubation.
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Nonenzymatic

Glucosylation

I

I

FRACTION
NUMBER
Fta. 3. Sephadex C-200 chromatography
of rat serum after
200 h of incubation
with [6-aH]~lucose. Hat serum was incubated
aa in Fig. 2, dialyzed for 16 h at 4’C against two changes (1066
volumes) of 0.1 M Tris-HCl, pH 7.8,l.O M NaCl, and chromatographed
on a G-260 column (1.5 x 63 cm, I-ml fractions). The cdumn was
eluted with the same buffer and the effluent monitored for protein
and “H radioactivity. Arrows indicate positions of IgM, IgG, and
albumin, respectively.

TIMlXDAYS)

FIa. 4. Comparison
of the effects of NaBfI&N
and aspirin
on the incorporation
of (S3~gllucose
into rat albumin in uitm.
Purified rat albumin, 7 mg, was incubated in 1 ml of Dulbecco’s
phosphate-buffered saline (16) containing 5 rnM glucose, 2 x 10’ cpm
of [6-“H]ghtcose, alone or with 17 mM NaBHEN or with 0.5 mM
aspirin, and acid-precipitable radioactivity was determined as described under “Materials and Methods.”

J-

0.50

5.0

6
g

0.25

2.5

ki
2
H

0

ul

2

0.50

0.10

D
t

0.25

FRACTION
NUMBER
Fro. 5. Separation
of ghnzosylated rat Elfbumin from unglucosylated albumin by carboxymethyleelluhrse
chromatography. Samples in 0.01 M sodium acetate, pH 4.65, were applied to a
column (17.5 x 2 cm, l-ml fractions) of carboxymethylcellul
and
washed with 10 column volumes of starting buffer. At the position
indicated by the arrow, the column was eluted using a 150~ml gradient
of 0.01 to 0.5 M sodium acetate, pH 4.65. A, chromatography of
albumin following glucosylation with [6-‘Hlglucose in vitro; B, chromatography of albumin purified from fresh rat serum; fractions monitored for protein and for ketoamine structures using the thiobarbituric acid assay (17).
presence of albumin (Peak II, Fig. 6). Thii product is not the
hexitol-lysine
itself (Pecsk Z, Fig. 6), but probably an anhydroderivative
of hexitol-lysine
produced during the hydrolysis
(13). Derivatives
of both mannitol- and glucitol-lysine
should
be obtained since the borohydride
reduction of the ketoamine
is not stereospec&,
however these isomers are apparently
not resolved in the standard elution scheme on the amino acid
analyzer. The small amount of radioactive material appearing
after Peak II has not been identified. From these results, we
conclude that intrachain
lysine residues, rather than the NH*terminal glutamate, are the primary sites of glucosylation
of
rat albumin.
Table II summarizes the results from carbohydrate
analyses
of hydrolysates
of [6-“H]glucose-labeled
albumin (prepared
nonenzymatically
in vitro) carried out under conditions commonly used for the analysis of neutral sugars in glycoproteins.
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(Fig. 3), radioactivity
was found associated with each of the
major molecular
weight classes of serum protein. Since the
highest specific activity (counts per mm/Am)
was observed
in the region corresponding
to serum albumin, we investigated
nonenzymatic
glucosylation
of purified rat albumin in further
detail.
Incorporation
of [6-‘H]glucose
into albumin was also linear
for at least 200 h at 22”C, as shown in Fig. 4. By 200 h, about
50% of the albumin had been converted to the glucosylated
form. The rate of glucosylation
was stimulated approximately
1.5-fold by the addition
of 1 mg/ml
of NaBH&N.
The
stimulation
by BHaCN- probably
results from selective reduction (23) of S&&base
adducts formed between glucose
and protein, pulling the initial equilibrium
reaction to the
right (Fig. 1). In contrast, aspirin inhibited
the rate of glucosylation, suggesting that at least some glucose is being incorporated at the lysine residue in rat albumin, which is the site
of acetylation
by aspirin (see below).
The glucosylated
rat albumin prepared in vitro was separable from unglucosylated
albumin by chromatography
on
CM-cellulose
(Fig. 5A). However, in contrast to our observations with human albumin
(12), glucosylated
rat albumin
eluted from the column after the unglucosylated
form. More
than 95% of the protein-bound
radioactivity
from [6-3H]glucase was associated with the second protein peak. Peak If
yielded a strong positive reaction in the thiobarbituric
acid
test for ketoamine derivatives
of protein (I7), white a weak
but reproducible
reaction was observed in Peak I (data not
shown). When native albumin, freshly purified from rat serum
by affinity chromatography,
was chromatographed
as above,
two peaks of protein were observed (Fig. 5B), corresponding
precisely to Peaks I and II obtained from the in vitro incubation (Fig. 5A); Peak II accounted for about 96% of the
thiobarbituric
acid reactivity. Ammo acid analyses of Peaks I
and II are essentially identical
(Table I), and agree closely
with results from hydrolysis of a commercia1 sample of purified rat albumin and published data (24). Based on relative
areas under Peaks I and II, normal rat serum contains about
6.7 f 0.9% (mean zb S.D., II = 8) glucosylated
albumin.
Verification
that a lysine residue is the major site of glucosylation was obtained
by amino acid analysis of an acid
hydrolysate of NaBH,-reduced
[6-“HIglucose-labeled
albumin
(Fig. 6). More than 90% of radioactivity
obtained from hydrolysis of the protein co-chromatographed
with the product
obtained from a separate hydrolysis of glucitol-lysine
in the

of Serum Proteins

Nonenzymatic

Ghcosylation

Hydrolysis for 2 or 4 h in 2 N trifluoroacetic
acid, HCl, H2S04,
or 4 N acetic acid resulted in the recovery of no more than 5%
of the starting radioactivity
in glucose and mannose, under
any of the conditions studied. More than 99% of the starting
radioactivity
was recovered as high molecular weight material,
either excluded from or partially
included in a Bio-Gel P-2
column. These data indicate that nonenxymatically
attached
glucose is likely to contribute
only trace amounts of glucose
or mannose to analyses of neutral sugars in glycoproteins.
The data in Figs. 7 to 9 summarize experiments describing
some of the kinetic and thermodynamic
properties
of the
glucosylation
of albumin in vitro. The influence of glucose
and albumin concentrations
on the rate of glucosylation
are
shown in Fig. 7A and 8A, respectively.
At higher glucose
concentrations,
the rate of glucosylation
appeared to decline
appreciably
after the addition
of 1 mol of glucose/mol
of
protein. The initial rate of glucosylation
of albumin in vitro is
first order with respect to both glucose (Fig. 7B) and albumin
(Fig. 8B) concentration
in the incubation
mixture, and second
order overall. As shown in Fig. 9, the rate of glucosylation
is

60

J
10

20

30

40

SO

tlYE(YINUtES)

FIG. 6. Amino
acid analysis
of rat albumin
after
glucosylation with [&‘H]glucose
and reduction
with NaBH,.
Hat albumin
was glucosylated
with [6-3H]glucose,
purified
by carboxymethylcellulose chromatography,
reduced
with NaBI&,
and hydrolyzed
for
amino acid analysis
as described
under “Materials
and Methods.”
Radioactivity
at “L” represents
added L-[JH]leucine
marker,
containing a trace contaminant
of isoleucine.
Peak Z represents
position
of
elution
of authentic
[“Hlglucitol-lysine.
Peak ZZ represents
position
of elution
of the “H-labeled
product
obtained
after hydrolysis
of
authentic
[‘Hlglucitol-lysine
at 199°C for 24 h in 6 N HCl in the
presence
of 1 mg/ml
of albumin.

I

Amino acid analyses of rat albumins
COmmSrCial
albumin’

96composition (nwl/lOO mol)
ASP
Thr

13.90

Ser
Glu
Pro
GUY
AIa
CYS
Val
Ile

4.99
16.74
5.24
4.21
12.23
2.56
3.57
0.77

5.39

IA?U

7.97

TY
Phe
His
LYS
Arg

4.81
4.80
2.35
8.14
3.60

14.09
5.38
5.12
16.81
5.19
4.23
12.35
2.54
3.51
0.77
a.12
4.89
4.80
2.35
8.19
3.70

13.53
5.26
4.94
16.23
4.91
4.31
12.77
2.42
3.45
0.82
a.02
4.58
4.70
2.39
8.16
3.69

TABLE

Hydrolysis

conditions”

Acid

hydrolysis

56 recoveryh
Time

MZiIUlOSZ

Glucose

(hl
2
4
2
4
2
4
2
4

2 N Trifluoroacetic
2~Hcl
2 N H&04
4 N Acetic

n Amino
acid analysis
carried
out following
hydrolysis
of protein
(1 mg/ml)
in 6 N HCl as described
under “Materials
and Methods.”
b Albumin
was purified
from rat serum by affinity
chromatography
on Affi-Gel
Blue (15) and separated
into glucosylated
and unglucosylated
fractions
by carboxymethylcellulo
chromatography
as described
for Fig. 4.
’ Hat albumin
was purchased
from Miles Laboratories.

A

II

Recovery of radioactive glucose and mannose following
of [6-3H]glucose-labeled
albumin

<l
Cl
tl
<l
tl
<l
<l
<l

2.7
4.2
2.3
3.7
<l
4.3
1.8
3.7

n [6-‘H]Glucose-labeled
albumin
(1 mol of glucose/mol
of albumin),
0.25 mg/ml,
containing
-40,000 cpm was hydrolyzed
in acids at 100°C
for various
times.
’ Carbohydrates
were separated
by ion exchange
chromatography
(18, 19), and recovery
of radioactivity
in individual
sugars was determined as described
under “Materials
and Methods.”

I

GLUCOSE

CONCENTRATION

(mM)

FIG. 7. Rate of glucosylation
of rat albumin
as a function
of glucose
concentration.
Hat albumin,
7 mg/ml
of phosphate-buffered
saline, was incubated
with indicated
concentrations
of glucose
made to a final specific
activity
of 4 x 10’ cpm/l.rmol.
A, acid-precipitable
radioactivity
in aliquots
removed
at indicated
times was determined
as described
under “Materials
and Methods.”
B, initial reaction
rates
shown in A are plotted
as a function
of glucose concentration.
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Glucosylation

of Serum

Proteins

T4
8=0.2
e
W
4
t

0.1

0
5
9
a

TIME (DAYS)
8. Rate of glucosylation
in phosphate-buffered
times was determined
concentration.

of rat albumin

as a function of albumin concentration.
Rat albumin
at indicated
concentrations
was
saline containing
5 mM glucose (4 x 10” cpm/pmol).
A, acid-precipitable
radioactivity
in aliquots
removed
at
as described
under “Materials
and Methods.”
B, initial reaction
rates shown in A are plotted as a function
of

r
x Unglucosyloted
l
Glucosylated

12

3

4

5

6

7

6

TIMEtDAYS)

9. Rate of glucosylation
of rat albumin as a function of
temperature.
Rat albumin,
25 mg/ml,
was incubated
in phosphateFIG.

buffered
saline
acid-precipitable
was determined

containing
5.0 mM glucose
(4 X 10” cpm/pmol)
radioactivity
in aliquots
removed
at indicated
as described
under “Materials
and Methods.”

and
times

I
7

:IME (DAYS)
FIG.

temperature-dependent,
but an Arrhenius plot of the data has
a convex curvature, prohibiting
a straightforward
determination of the activation
energy of the glucosylation
reaction.
The extent of reaction was negligible during 120 days storage
in the freezer at -20°C.
In Vivo Studies-In
order to estimate the rate of formation
of glucosylated
albumin in uiuo, and to evaluate its in vivo
stability, animals were injected with either unglucosylated
or
glucosylated
““I-albumin.
Carboxymethylcellulose
chromatography of the albumin reisolated at various times postinjection was used to monitor any shifts of lz51 radioactivity
from
one form of the albumin
to the other. At 1 and 3 days
postinjection
of ‘“51-unglucosylated
albumin,
3.0 and 7.9%,
respectively,
of the recovered ““I-albumin
was found in the
glucosylated
fraction. These results document that glucosylation is a post-translational
modification
occurring
in the
circulation. Glucosylation
is apparently an irreversible process
in vivo since no lz51 radioactivity
was recovered
from the
unglucosylated
region of the carboxymethylcellulose
column
for as.,>rlong as 3 days (1.5 half-lives) after injection of glucosylated ““I-albumin.

5

I

sylated

Kinetics of clearance of glucosylated
‘251-albumins from the rat circulation.

10.

and unglucoAlbumin was

iodinated,
glucosylated,
and separated
into glucosylated
and unglucosylated
components
by carboxymethylcellulose
chromatography,
all as described
under “Materials
and Methods.”
Animals
(two/experiment)
were injected
with one or the other form of the albumin,
and the disappearance
of la5I radioactivity
from the circulation
monitored in blood samples taken at indicated
times. Time of equilibration
of albumin
into extravascular
space indicated
by - - -.

The structure of carbohydrate
side chains are known to
influence
profoundly
the metabolism
of plasma proteins.
Therefore, we investigated
the possible role of glucosylation
in regulating albumin clearance from the circulation, by studying the half-lives of glucosylated
and unglucosylated
12”1-albumin. Iodination
was carried out prior to glucosylation
to
avoid the possibility that the conditions of iodination
might
modify the nature of the glucosyl adduct. The circulating halflife of both iodinated forms of albumin (Fig. 10) was found to
be 48 h, indicating
that glucosylation
does not affect the
fractional catabolic rate for albumin in the circulation.
Since the rate of glucosylation
in vitro is first order with
respect to glucose concentration
(Fig. 7), higher rates of glu-
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FIG.
incubated
indicated
albumin

Nonenzymatic
TABLE

Relationship

III

between blood glucose and levels of glucosylated
urotein in control and diabetic rats
Normal

Blood glucose mg/lOO mlh
% Glucosvlated albumin’
” Data

are

Ghcosylation

for two

rats

Diz&&km-

70, 73.5
7.2. 8.1
maintained

Diabetic +
insulin

434,444
31.0, 33.8
under

each

go,92
18.8, 18.0

set of conditions

described under “Materials
* Measured
‘Determined
Fig. 5.

and Methods.”
by glucose-oxidase
peroxidase procedure.
by CM-cellulose

chromatography

as described

for

DISCUSSION

The studies presented here, along with our previous report
(12), indicate that nonenzymatic
glucosylation
is a common
post-translational
modification
of serum proteins. The observation that albumin is particularly
reactive to nonenzymatic
glucosylation,
its ease of purification,
and the fact that albumin is a well characterized
plasma protein led us to investigate
nonenzymatic
glucosylation
of this protein as a model for
other plasma proteins.
The rate of glucosylation
of rat albumin in vitro appears to
be fiit order with respect to glucose concentration,
but slows
down abruptly after transfer of approximately
1 mol of glucose/mol of protein (Fig. 7A), suggesting the presence of a
single, rapidly modified amino acid residue, and other less
reactive secondary sites. From studies of glucosylated albumin
prepared in vitro, we have identified a lysine residue(s) as the
major site(s) of glucosylation
of albumin (Fig. 6). The inhibition of glucosylation
by aspirin (acetylsalicylic
acid) suggests
that this is the same low pK lysine residue which is acetylated
by aspirin (25). Studies are in progress to verify this assignment.
Variations
in oxygen binding equilibria
for several HbAi
subfractions
have been documented
(4, 5) suggesting long
range conformational
alterations
in hemoglobin’s
tertiary or
quaternary
structure upon glucosylation.
Similarly,
glucosylation of albumin might also affect its affinity for a variety of
ligands, including
fatty acids, bilirubin,
clinical dyes, and
pharmacological
agents. As a minimum,
glucosylation
undoubtedly
contributes
to the well known structural
microheterogeneity
of albumin
(26), and may be responsible
for
some of the multiple electrophoretic
forms observed for this
and other proteins by high resolution techniques.
While the actual mechanisms
regulating
plasma protein
catabolism are poorly understood, there is good evidence that
albumin
is catabolized,
at least in part, directly
from the
vascular compartment
(27). Foster has suggested that albumin’s catabolism may be the end result of a series of chemical
or enzymatic insults to the protein, which take place in the
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circulation,
and contribute
to its gradual denaturation
(26).
Since variations in the structure of carbohydrate
side chains
are known to have a critical role in regulating the uptake and
catabolism of circulating
glycoproteins
(28, 29), we hypothesized that glucosylation
might be a chemical insult initiating
albumin’s catabolism. Our data, however, do not support this
hypothesis
(Fig. lo), but suggest that glucose attached nonenzymatically
to albumin
does not serve as a recognition
marker triggering
specific removal of the glycoprotein
from
the circulation
in normal rata.
Since glucosylation
does not affect albumin’s
circulating
half-life, it is possible, by a relatively straightforward
kinetic
analysis, to predict the steady state level of glucosylated
albumin in uiuo from knowledge of the kinetics of glucosylation and catabolism of albumin in uiuo. The relationship
may
be written:
-d[GAl = k’,[A] - kz[GA]
dt
where GA = glucosylated
albumin, A = unglucosylated
albumin, and k’, and k:! are rate constants for glucosylation
and
catabolism of albumin. (For convenience k’l is treated here as
a pseudo-fist
order rate constant, although
the synthetic
reaction is second order overall, i.e. k’, = kl [glucose].) Then,
at steady state,
dIGA]dt

0

and
k’l
[GA]
kz
-=[A].

(1)

The in uiuo rate constant, k’,, can be estimated from the
observation
that about 7.9% of injected, unglucosylated
1251albumin isolated at 3 days postinjection
was recovered as the
glucosylated
form. Thus, k’, = 0.026 day-’ = 0.0011 h-‘.
Similarly, from the half-life of glucosylated albumin shown in
Fig. 10,
k 2-= 06g3 - 06g3 - 0.014 h-1,
48 h
h/2
These estimates of rate constants are, within experimental
error, consistent with the observed steady state level of glucosylated albumin in rat serum, as predicted in Equation
I,

i.e.
k’,
-=
kz
and, since approximately
the glucosylated
form,

0.0011 h-’
o.014 h-,

= 0.078

6.7% of albumin

[GA]

[Al

= 0.067
0.93

exists normally

in

= 0,072,

The agreement between these two ratios indicates that the
rate of nonenzymatic
glucosylation
in the extracellular
compartment in uiuo is adequate to explain the steady state level
of glucosylated
albumin in the circulation,
and argues that
glucosylation
occurs as a postsecretory,
rather than an intracellular, event. The rate of glucosylation
of albumin observed
in serum at 37°C in vitro, 37% in 200 h, k’, = 0.0018 h-’ (data
not shown) is reasonably close to the value observed in uiuo.
However, the rate observed with purified albumin at 37°C in
vitro was faster, 61% in 200 h, k’l = 0.0031 h-l; thus, the
glucosylation
reaction proceeds more rapidly with the pure
protein in vitro, suggesting that other ligands bound to albumin may inhibit the rate of glucosylation
in serum.
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cosylation
of albumin
might be expected to occur during
diabetic hyperglycemia
in uiuo. In addition, because glucosylation does not affect the half-life of albumin in the circulation
(Fig. lo), higher steady state levels of glucosylated
albumin
should be observed in diabetic animals. This prediction
was
confirmed by measurements
of per cent glucosylated
albumin
in normal and diabetic rata (Table III). Highest levels of
glucosylated
albumin are observed in untreated, diabetic animals, and the 4-fold elevation
of glucosylated
albumin
is
comparable to the 6-fold increase in blood sugar. A significant,
2.5-fold, elevation in glucosylated albumin is also observed in
insulin-treated
diabetic animals, suggesting that overall control of hyperglycemia
is suboptimal
although
fasting blood
glucose is near normal.
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In the past, the detection of low levels of glucose in noncollagen glycoproteins has often been attributed to trace contamination by cellulosic materials. Within the last few years,
however, glucose has been identified as a component of the
oligosaccharide of both lysosomal enzymes (30) and intracellular intermediates in the processing of secreted and membrane glycoproteins (31). It was important, therefore, to determine the extent to which nonenzymatically bound glucose
could interfere with analyses for glucose in glycosidic linkage
to protein. From the data in Table II, however, it is clear that
nonenzymatically bound glucose is not likely to affect carbohydrate analyses on glycoproteins. Only trace amounts (~5%)
of free glucose or mannose were released under standard
conditions for hydrolysis of neutral sugars. Since more than
75% of the radioactivity in the hydrolysates was partially or
completely excluded from Bio-Gel P-2, and adsorbed to mixed
bed resins, it is likely that the glucose residue is released from
the protein in a peptide-bound form. Based on the model
studies of Heyns et al. (2,32), the glucose may be found in the
peptide as an e-N-(2furoyhnethyl)- derivative of lysine.
In the preliminary experiments reported here, we observed
that untreated diabetic hyperglycemia in the rat results in
about a 4-fold increase in per cent glucosylated albumin, while
insulin-treated diabetic rats have about a 2-fold elevation. It
should be emphasized that the insulin regimen used in these
experiments is designed both to provide for the convenient,
daily administration of a long acting insulin, and to be adequate to prevent glucosuria and ketoacidosis. However, the
regimen is not optimized for the individual animals, and
variations in blood glucose do occur during the daily cycle. In
fact, the elevated level of glucosylated albumin in the insulintreated animals may be a better indicator of a mild hyperglycemic state than the single fasting blood glucose measurements. Further studies in rata which monitor changes in per
cent glucosylated albumin during both uncontrolled hyperglycemia and therapeutic management with insulin should permit an evaluation of the sensitivity of glucosylated albumin to
average blood glucose levels. The enhanced levels of glucosylated albumin detected in diabetic rata suggest that measurements of albumin glucosylation in man may also be useful in
the detection and management of diabetes,
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